DUBLIN–(BUSINESS WIRE)–The “Global Regulatory Affairs Outsourcing Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.
The regulatory affairs outsourcing market is poised to grow by $4.63 bn during 2022-2026, progressing at a CAGR of 12.15% during the forecast period
This study identifies the high regulatory compliance associated with healthcare as one of the prime reasons driving the regulatory affairs outsourcing market growth during the next few years. The market is driven by the growth of the pharmaceutical industry and the availability of cost-efficient resources in emerging markets.
The report on the regulatory affairs outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The regulatory affairs outsourcing market analysis includes the end-user segment and geographic landscape.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regulatory affairs outsourcing market vendors that include Certara Inc., Charles River Laboratories International Inc., Genpact Ltd., Icon Plc, Laboratory Corp. of America Holdings, Medpace Holdings Inc., PPD Inc., PRA Health Sciences Inc., ProPharma Group Holdings LLC, and WuXi AppTec Co. Ltd.
Also, the regulatory affairs outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
Key Topics Covered:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 – 2026
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Pharmaceutical – Market size and forecast 2021-2026
- Medical device – Market size and forecast 2021-2026
- Biotechnology – Market size and forecast 2021-2026
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- APAC – Market size and forecast 2021-2026
- North America – Market size and forecast 2021-2026
- Europe – Market size and forecast 2021-2026
- ROW – Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Certara Inc.
- Charles River Laboratories International Inc.
- Genpact Ltd.
- Icon Plc
- Laboratory Corp. of America Holdings
- Medpace Holdings Inc.
- PPD Inc.
- PRA Health Sciences Inc.
- ProPharma Group Holdings LLC
- WuXi AppTec Co. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/e6g2hx.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900